Unilateral Training of the Uninjured Limb on Clinical Outcomes in Patients with Surgically Treated Radius Fracture
Launched by UNIVERSIDAD CATOLICA DE TEMUCO · Nov 18, 2024
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective additional training for the uninjured arm can be for patients recovering from a wrist fracture (specifically a distal radius fracture) after surgery. The goal is to see if this extra training, combined with standard rehabilitation, can improve grip strength and hand movements better than just standard rehabilitation alone. The trial will involve adults aged 30 to 50 who have had surgery for a broken wrist, and it will last for 12 weeks.
To participate, individuals must be between 30 and 50 years old, have a specific type of wrist fracture that has been surgically treated, and not have certain health conditions that could interfere with recovery. Participants will be randomly placed into one of two groups: one will receive standard rehabilitation with some mobility exercises, and the other will get standard rehabilitation plus more intense strength training for the uninjured arm. Throughout the study, their grip strength, hand movements, and overall wrist function will be measured at different times to see how they improve. It’s important to note that the trial has not started recruiting participants yet.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age between 30-50 years
- • Radiological diagnosis of unilateral distal radius fracture without concomitant fractures.
- • Fracture treated surgically.
- Exclusion Criteria:
- • Patients with lesion of the triangular fibrocartilage.
- • Patients with distal radius fracture with consolidation disorders.
- • Patients with health conditions that cause pain or affect the motor skills of the upper limb (radiocarpal osteoarthritis, carpal tunnel syndrome, Quervain's tenosynovitis, neurodegenerative diseases, sequelae of stroke)
- • Patients with multi-site pain or chronic polyarticular diseases such as osteoarthritis or rheumatoid arthritis.
- • Unstable cardiovascular, respiratory, systemic or metabolic conditions that do not allow high-intensity physical exercise.
- • Patients who are taking nutritional supplements that interfere with the regulation of skeletal muscle strength and mass (example: whey protein, creatine, etc.)
- • Inability to understand, read and/or speak the Spanish language.
About Universidad Catolica De Temuco
Universidad Católica de Temuco is a leading academic institution in Chile, recognized for its commitment to advancing research and education in the health sciences. With a strong emphasis on innovation and community engagement, the university actively sponsors clinical trials aimed at addressing critical health issues and improving patient outcomes. Its experienced team of researchers and healthcare professionals collaborates closely with local and international partners to ensure the highest standards of scientific integrity and ethical conduct in all clinical studies. Through these efforts, Universidad Católica de Temuco strives to contribute to the global body of medical knowledge while enhancing the health and well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Temuco, , Chile
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported